These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23408680)

  • 21. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.
    Unemo M; Golparian D; Potočnik M; Jeverica S
    Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharyngeal Gonorrhea in female sex workers: Response to a single 2-g dose of azithromycin.
    Dan M; Poch F; Amitai Z; Gefen D; Shohat T
    Sex Transm Dis; 2006 Aug; 33(8):512-5. PubMed ID: 16572040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhea in pregnancy.
    Ramus RM; Sheffield JS; Mayfield JA; Wendel GD
    Am J Obstet Gynecol; 2001 Sep; 185(3):629-32. PubMed ID: 11568790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT.
    Ross JD; Harding J; Duley L; Montgomery AA; Hepburn T; Tan W; Brittain C; Meakin G; Sprange K; Thandi S; Jackson L; Roberts T; Wilson J; White J; Dewsnap C; Cole M; Lawrence T
    Health Technol Assess; 2019 May; 23(20):1-104. PubMed ID: 31099330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and treatment outcomes of pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections in men who have sex with men: a 13-year retrospective cohort study.
    Ota KV; Fisman DN; Tamari IE; Smieja M; Ng LK; Jones KE; Diprima A; Richardson SE
    Clin Infect Dis; 2009 May; 48(9):1237-43. PubMed ID: 19323630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.
    Taylor SN; Marrazzo J; Batteiger BE; Hook EW; Seña AC; Long J; Wierzbicki MR; Kwak H; Johnson SM; Lawrence K; Mueller J
    N Engl J Med; 2018 Nov; 379(19):1835-1845. PubMed ID: 30403954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014.
    Golparian D; Ohlsson A; Janson H; Lidbrink P; Richtner T; Ekelund O; Fredlund H; Unemo M
    Euro Surveill; 2014 Jul; 19(30):. PubMed ID: 25108533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial.
    Rob F; Klubalová B; Nyčová E; Hercogová J; Unemo M
    Clin Microbiol Infect; 2020 Feb; 26(2):207-212. PubMed ID: 31419483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.
    Y Chen M; Stevens K; Tideman R; Zaia A; Tomita T; Fairley CK; Lahra M; Whiley D; Hogg G
    J Antimicrob Chemother; 2013 Jun; 68(6):1445-7. PubMed ID: 23390207
    [No Abstract]   [Full Text] [Related]  

  • 30. A Case of Persistent and Possibly Treatment Resistant Pharyngeal Gonorrhea.
    Levy V; Pandori M; Berrada ZL; Relucio KI; Lopez TP; Samuel MC; Park IU
    Sex Transm Dis; 2016 Apr; 43(4):258-9. PubMed ID: 26967304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharyngeal gonorrhoea - is dual therapy the way forward?
    Sathia L; Ellis B; Phillip S; Winston A; Smith A
    Int J STD AIDS; 2007 Sep; 18(9):647-8. PubMed ID: 17785013
    [No Abstract]   [Full Text] [Related]  

  • 32. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
    Harry TC
    Int J STD AIDS; 2005 Jul; 16(7):520. PubMed ID: 16004640
    [No Abstract]   [Full Text] [Related]  

  • 33. Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada.
    Martin I; Sawatzky P; Liu G; Allen V; Lefebvre B; Hoang L; Drews S; Horsman G; Wylie J; Haldane D; Garceau R; Ratnam S; Wong T; Archibald C; Mulvey MR
    Emerg Infect Dis; 2016 Jan; 22(1):65-7. PubMed ID: 26689114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gentamicin Alone Is Inadequate to Eradicate Neisseria Gonorrhoeae From the Pharynx.
    Barbee LA; Soge OO; Morgan J; Leclair A; Bass T; Werth BJ; Hughes JP; Golden MR
    Clin Infect Dis; 2020 Nov; 71(8):1877-1882. PubMed ID: 31712813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azithromycin in the treatment of infection with Neisseria gonorrhoeae.
    Bignell C; Garley J
    Sex Transm Infect; 2010 Nov; 86(6):422-6. PubMed ID: 20940153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(18):579-81. PubMed ID: 21566558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACOG Committee Opinion No. 645: Dual Therapy for Gonococcal Infections.
    Committee on Gynecologic Practice
    Obstet Gynecol; 2015 Nov; 126(5):e95-9. PubMed ID: 26488526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Committee Opinion No. 645 Summary: Dual Therapy for Gonococcal Infections.
    Obstet Gynecol; 2016 May; 127(5):1126. PubMed ID: 27548417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACOG Committee Opinion No. 645 Summary: Dual Therapy for Gonococcal Infections.
    Committee on Gynecologic Practice
    Obstet Gynecol; 2015 Nov; 126(5):1126. PubMed ID: 26488518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.